Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009
The prevalence and spread of azole resistance in clinical Aspergillus fumigatus isolates in the Netherlands are currently unknown. Therefore, we performed a prospective nationwide multicenter surveillance study to determine the effects of resistance on patient management strategies and public health. From June 2007 through January 2009, all clinical Aspergillus spp. isolates were screened for itraconazole resistance. In total, 2,062 isolates from 1,385 patients were screened; the prevalence of itraconazole resistance in A. fumigatus in our patient cohort was 5.3% (range 0.8%–9.5%). Patients wi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2011 |
Reihe/Periodikum: | Emerging Infectious Diseases, Vol 17, Iss 10, Pp 1846-1854 (2011) |
Verlag/Hrsg.: |
Centers for Disease Control and Prevention
|
Schlagwörter: | Aspergillosis / fungal infections / aspergillus / antifungal drug resistance / outcome assessment / prevalence / Medicine / R / Infectious and parasitic diseases / RC109-216 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29169902 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.3201/eid1710.110226 |